Drugs / Iodopovidone
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02674243 | Nov 2015 → Dec 2019 | pleural neoplasm | Chiang Mai University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03325192 | Dec 2017 → Jul 2019 | pleural disorder | University of Pennsylvania | Terminated | No outcome recorded Stop: Enrollment |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00692757 Comparator | Jul 2008 → Jan 2009 | — | Universidad Tecnológica de Pereira | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iodopovidone | “20mL of 10% iodopovidone and 80mL of normal saline will be instilled into the pleural space” NCT03325192 ↗ |
| Route | Topical | “in preoperative scrub of surgical area” NCT00692757 ↗ |